Having Trouble Staying Regular New Medication May Offer Relief
Below is a MRR and PLR article in category Health Fitness -> subcategory Medicine.
Title: Struggling with Constipation? Discover a New Solution
Summary:
Constipation might not be a popular topic, but it's surprisingly common, affecting millions. A new medication offers hope for those seeking relief.
Article Body:
Constipation often doesn’t make it into casual conversations, yet it's a widespread issue impacting more than 30 million Americans. Annually, it's responsible for 2.5 million doctor visits and 92,000 hospital stays.
Beyond being inconvenient, constipation can cause significant abdominal pain and discomfort, potentially affecting one's quality of life, especially when chronic.
John Johanson, M.D., Clinical Associate Professor at the University of Illinois College of Medicine at Rockford, explains, "Traditional treatments like increasing fiber intake, staying hydrated, and using laxatives or stool softeners often prove unsatisfactory. They can lose efficacy over time, worsen the issue, or cause side effects such as bloating or gas."
Fortunately, there's now a promising new treatment for chronic idiopathic constipation. Recently approved by the FDA, AMITIZA™ (lubiprostone) provides effective and reliable relief for adults battling this condition.
Constipation happens when there's insufficient fluid in the intestine, leading to hard stools and difficulty in passing bowel movements. AMITIZA helps by increasing fluid secretion, easing stool passage, and alleviating symptoms of chronic idiopathic constipation.
Dr. Johanson remarks, "The availability of AMITIZA is exciting news for millions of Americans managing chronic idiopathic constipation and its daily challenges."
For more information on managing chronic constipation with various treatments alongside diet and exercise, consult your healthcare provider.
Important Product Information:
AMITIZA is designed to treat chronic idiopathic constipation in adults. It should not be used by individuals with known allergies to its components or those with mechanical gastrointestinal obstructions. Before starting treatment, patients with symptoms of such obstructions should be evaluated.
AMITIZA's safety during pregnancy hasn't been established in humans. In animal studies, it has shown potential to harm the fetus. Use during pregnancy should be justified by a clear benefit. Women who might become pregnant should have a negative test before starting AMITIZA and use effective birth control.
Patients with severe diarrhea should avoid AMITIZA and monitor for diarrhea during treatment, consulting their healthcare provider if it worsens.
In clinical trials, the most common side effect was nausea (31%). Other reported effects (≥5% of patients) included diarrhea (13%), headache (13%), abdominal distention (7%), abdominal pain (7%), flatulence (6%), sinusitis (5%), and vomiting (5%).
You can find the original non-AI version of this article here: Having Trouble Staying Regular New Medication May Offer Relief.
You can browse and read all the articles for free. If you want to use them and get PLR and MRR rights, you need to buy the pack. Learn more about this pack of over 100 000 MRR and PLR articles.